Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 3—March 2022
Synopsis

Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020

Côme DaniauComments to Author , Emmanuel Lecorche, Faiza Mougari, Hanaa Benmansour, Claude Bernet, Hervé Blanchard, Jérôme Robert, Anne Berger-Carbonne, and Emmanuelle Cambau
Author affiliations: Santé Publique France, Saint-Maurice, France (C. Daniau, A. Berger-Carbonne); Université de Paris, Paris, France (E. Lecorche, E. Cambau); Assistance Publique Hôpitaux de Paris, Paris (E. Lecorche, F. Mougari, H. Benmansour, H. Blanchard, J. Robert, E. Cambau); Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris (E. Lecorche, F. Mougari, H. Benmansour, J. Robert, E. Cambau); Centre d’Appui pour la Prévention des Infections Associées aux Soins en Provence-Alpes-Côte-d’Azur, Lyon, France (C. Bernet); Centre d’Appui pour la Prévention des Infections Associées aux Soins en Île-de-France, Paris (H. Blanchard); Centre d’Immunologie et des Maladies Infectieuses (CIMI),; Sorbonne Université, Paris (J. Robert)

Main Article

Table 1

Description of 85 reported healthcare and aesthetic-associated NTM infections, France, 2012–2020*

Procedure Infection type Sex, M/F Median age, y (range) Infection risk factor Median incubation times, d (range) Species implicated
Surgical, n = 48
Cardiovascular surgery, n = 14 Infective endocarditis and aortic infection, n = 13 7/3, NR = 3 69 (47‒81); n = 10; NR, n = 3 None, n = 10; NR, n = 3 393 (14‒732); n = 11; NR, n = 2 M. chelonae, n = 5; M. chimaera, n = 3; AFB positive and culture negative, n = 2; M. wolinskyi, n = 1; M. avium, n = 1; M. abscessus,† n = 1; M. lentiflavum,† n = 1; M. fuerthensis,† n = 1
SST, n = 1 0/1 69 None 41 M. fortuitum complex, n = 1
Breast surgery, n = 13 SST 1/12 42 (31‒53); n = 10; NR, n = 3 Breast cancer, n = 2; HIV, n = 1; none, n = 8; NR, n = 2 36 (10‒732); n = 12; NR, n = 1 M. fortuitum, n = 6; M. abscessus, n = 3; M. senegalense, n = 1; M. chelonae, n = 1; M. avium, n = 1; M. chimaera, n = 1
Orthopedic Surgery, n = 11 Bone and joint 5/2, NR = 4 69 (45‒86); n = 7; NR, n = 4 None, n = 6; NR, n = 5 33 (23‒183); n = 9, NR, n = 2 M. fortuitum, n = 4; M. abscessus, n = 3; M. mageritense, n = 2; M. porcinum, n = 1; M. chelonae, n = 1
Skin surgery,‡ n = 7 SST 4/3 65 (42‒78); n = 6; NR, n = 1 None, n = 6; NR, n = 1 45 (30‒93); n = 6, NR, n = 1 M. fortuitum, n = 3; M. chelonae, n = 2; M. abscessus, n = 1; M. neoaurum, n = 1
Other surgery,§ n = 3 Vascular, n = 1 NR NR NR NR M. fortuitum, n = 1
Urogenital, n = 1 0/1 48 None NR M. fortuitum, n = 1
Ocular, n = 1
 0/1
 83
 None
 15
 M. chelonae, n = 1
Invasive, n = 28
Vascular catheter insertion, n = 17 Intravascular catheter 7/10 58 (4‒82); n = 17 Chemotherapy, n = 14; none, n = 2; NR = 1 NR M. chelonae, n = 6; M. mucogenicum, n = 5; M. abscessus, n = 2; M. fortuitum, n = 1; M. fortuitum complex, n = 1; M. porcinum, n = 1; M. neoaurum, n = 1
Infiltration, n = 3 Bone and joint 0/3 52 (52‒84); n = 3 Corticosteroid infiltration, n = 3 61 (33‒108); n = 3 M. abscessus, n = 2; M. chelonae, n = 1
Mesotherapy, n = 3 SST 1/2 47 (35‒49); n = 3 None, n = 3 30 (15‒73); n = 3 M. chelonae, n = 2; M. abscessus, n = 1
Tattoo, n = 3 SST 3/0 50 (48‒56); n = 3 None, n = 3 NR M. chelonae, n = 3
Intestinal endoscopy, n = 2
 Abdominal
 0/2
 68 (60‒75); n = 2
 Kidney transplant, n = 1; none, n = 1
 7 (4‒10); n = 2
 M. fortuitum, n = 1; M. abscessus, n = 1
Noninvasive, n = 4
Eye lens use, n = 3 Ocular 0/3 36 (21‒62); n = 3 None, n = 3 NR M. chelonae, n = 3
Balneotherapy, n = 1
 SST
 0/1
 51
 Methotrexate plus corticosteroids treatment
 20
 M. marinum, n = 1
Not identified, n = 5
SST, n = 3 1/2 44 (28‒75); n = 3 Kidney transplant, n = 1; NR = 2 NR M. chelonae, n = 3
Disseminated, n = 1 1/0 64 Corticosteroids treatment, chronic dialysis NR M. chelonae, n = 1
Bone and joint, n = 1 1/0 61 Corticosteroids treatment NR M. chelonae, n = 1

*AFB, acid-fast bacilli; NR, not reported; NTM, nontuberculous mycobacteria; SST, akin and soft tissue. †Sample that had several bacteria identified. ‡Skin operations concerning the following diverse procedures: face-lift, n = 2, abdominoplasty, n = 1, capillary implant, n = 1, excision of a basal cell carcinoma, n = 1, wearing a Holter monitor, n = 1 and neurostimulation device, n = 1. §Lower limb vascular surgery, n = 1, promontofixation, n = 1, eye surgery, n = 1.

Main Article

Page created: December 03, 2021
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external